Get access to our best features
Get access to our best features
Published 1 month ago

Business Meeting Rooms | Tailor-made mRNA to fight cancer and rare diseases Modena revolutionizes healthcare with technology

Summary by 星島頭條網
The COVID-19 pandemic brought messenger ribonucleic acid (mRNA) technology into the public eye. Take a closer look at the COVID-19 vaccine research and development teams, mostly from large traditional pharmaceutical companies. Taking “Fubitai,” which Hong Kong people are familiar with, as an example, it was jointly developed by German biotech company BioNTech and the US pharmaceutical company Huirui. Moderna (Moderna), which has only been establ…

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)